← Leaderboards
Xiaofeng Li
Abbratech, Inc.
$1,843,247
Attributed
$1,843,247
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $995.8K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,843,247 · 2
By mechanism
R44$1,843,247 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Antibodies”
- Jason Dickens · Duke University$12,259,409
- Jeff T Hutchins · Inhalon Biopharma, Inc.$11,188,896
- Robert C Alexander · Banner Health$8,197,111
- Shaunna Shen · Duke University$7,747,008
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
Research focus
AntibodiesInnovationTechnologyValidationBindingAmino AcidsProteinsSiteVariantAffinityGenetic PolymorphismScreeningAutoantigensAce2GenerationsAntigensEvolutionFightingCellsDesignB-LymphocytesAffect2019-NcovEmpowerment
Grant awards (3)
DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE Abs$551,373
R44 · FY2025 · GM · contact PI
Structure-guided neutralizing antibodies developed using EpiVolve technology$995,774
R44 · FY2024 · AI · contact PI
Structure-guided neutralizing antibodies developed using EpiVolve technology$296,100
R44 · FY2023 · AI · contact PI